Core Laboratories N.V.CLBNYSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank7
3Y CAGR+0.2%
5Y CAGR-3.6%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+0.2%/yr
vs -12.3%/yr prior
5Y CAGR
-3.6%/yr
Recent acceleration
Acceleration
+12.5pp
Accelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 12.06% | -13.8% |
| 2024 | 13.99% | +1.3% |
| 2023 | 13.81% | +15.3% |
| 2022 | 11.98% | -11.6% |
| 2021 | 13.56% | -6.3% |
| 2020 | 14.47% | -22.4% |
| 2019 | 18.65% | -7.8% |
| 2018 | 20.22% | -0.8% |
| 2017 | 20.38% | +6.0% |
| 2016 | 19.22% | - |